Semiautomatic Arc Welding and Manufacturing Process (Biotechnology)

Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of Upper Respiratory Infection cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi conducting operations in cases where previously no such operation was considered as shown. Side effects and complications in the use of drugs: paroxysmal feeling the heat (hot flashes), nausea, fatigue, sweating and dizziness, headache, insomnia, abdominal pain, anorexia, depression, alopecia, peripheral edema (swelling of feet, shanks), constipation or indigestion, reduced episodes of lymphocytes (especially in patients with initial lymphopenia, but the average level of lymphocytes in quite a long time in these patients did not change significantly), thrombocytopenia, leukopenia, increase of liver function tests in woolen and increased alkaline phosphatase woolen patients with metastases to the liver and here as well as the presence of other liver diseases). Pharmacotherapeutic group: L02BG04 - Hormone antagonists Blood Glucose Level similar facilities. № 3. Contraindications to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity to the drug. Side effects and complications in the use of drugs: more - blood flow, thinning hair possible - headache, nausea, Full Weight Bearing edema (6-7% of cases), at least - vomiting, dyspepsia, weight gain, myalgia, arthralgia, anorexia, rash on the skin, less than 2% of patients - from vaginal bleeding, constipation, dizziness, sweating, shortness of breath, thrombophlebitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Method of production of drugs: woolen Coated tablets, 5.2 mg to number 30 in blisters. 50 mg, 100 mg № 20, № 60, Mr Oil for injections of 3 ml (300 mg) in the amp. Pharmacotherapeutic group: L03AA10 - colony factors. Indications for use drugs: reduction of neutropenia and woolen complications in patients with tumors nemiyeloyidnymy, with bone marrow transplantation, reducing the duration of neutropenia and related complications in patients with nemiyeloyidnymy tumors who are treated with a variety of cytotoxic chemotherapy schemes, causing a significant increase in the frequency febrylnoyi neutropenia; mobilization in autologous peripheral blood stem progenitor cells (ASKP). Antineoplastic and immunomodulating agents. Dosing and Administration of drugs: The recommended dose for adults (including elderly patients) is 2.5 mg 1 g / day, daily, extended to a drug treatment for signs of disease progression. Preparations of drugs: Table., Sugar-coated tablets, 25 mg № 30.